Thermo Fisher Scientific has revised its Applied Biosystems TaqMan SARS-CoV-2 Mutation Panel to facilitate direct identification of the Omicron variant of the virus. Made with an adaptable menu of real-polymerase chain reaction (PCR) genotyping assays, the panel can precisely detect all known Covid-19 variants in nearly over an hour. The panel works with real-time PCR devices that are currently utilised in laboratories across the globe. Labs may make their own unique, highly scalable panel by selecting from a menu of more than 50 known mutations of the virus. Furthermore, it can process up to several specimens to check for various mutations at the same time.